@inproceedings{inproceedings, title  = {{MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.jtho.2023.09.154 }},

 year = {{2023}},

 month = {{11}},

 author = {{Middleton G and Fletcher P and Savage J and Mehmi M and Greystoke A and Dangoor A and Cave J and Escriu C and Shaw P and Steele N and Jain P et al}},

 doi = {{10.1016/j.jtho.2023.09.154}},

 volume = {{18}},

 journal = {{Journal of Thoracic Oncology}},

 issue = {{11}},

 pages = {{S119-S120}},

 note = {{Accessed on 2024/12/26}}}